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ABSTRACT  
A systematic review of published evidence on micronutrient intake/status with carbohydrate-
restricted diets (CRD) was conducted in Web of Science, Medline, Embase, Scopus, 
CENTRAL, and ClinicalTrials.gov up to October 2018.  We identified ten studies: seven 
RCTs (‘Atkins’-style, n=5; ’paleolithic’ diets, n=2), two Atkins-style non-controlled trials and 
one cross-sectional study. Prescribed carbohydrate varied 4%-34% of energy intake. Only 
one non-controlled trial prescribed multivitamin supplements. Dietary intakes/status were 
reported over 2-104 weeks, with weight losses 2-9 kg. No diagnoses of deficiency were 
reported.  Intakes of thiamine, folate, magnesium, calcium, iron, and iodine all decreased 
significantly (-10 to -70% from baseline) with any CRD types.  Atkins diet trials (n=6; 4-34%E 
carbohydrate) showed inconsistent changes in vitamin A, E and β-carotene intakes, while a 
single ‘paleolithic’ diet trial (28%E carbohydrate) reported increases in these micronutrients. 
One other ‘paleolithic’ diet (30%E carbohydrate) reported a rise in moderate iodine 
deficiency from 15% to 73% after 6 months. In conclusion, few studies have assessed the 
impacts of CRD on micronutrients. Studies with different designs point towards reductions in 
several vitamins and minerals, with potential risk of micronutrient inadequacies.  Trial 
reporting standards are expected to include analysis of micronutrient intake/status.  
Micronutrients in foods and/or supplements should be considered when designing, 
prescribing or following CRDs.  
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Abbreviations 
RCT, randomised controlled trial 
CHO, carbohydrate 
PRISMA, Preferred Reporting Items of Systematic reviews and Meta-analyses 
CENTRAL, Cochrane Central Register of Controlled Trials 
RNI, Reference Nutrient Intake 
EAR, estimated average requirement 
RBC, red blood cell 
DRV, dietary reference values  
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INTRODUCTION 
Carbohydrate-restricted diets have been promoted and used globally for weight 
management, and for treatment of diabetes, under either medical supervision or self-
guidance. The Health Information National Trends Survey (USA) of 5,586 participants 
reported high awareness of carbohydrate-restricted diet (86.6%) with 17% of responders 
having tried this diet (1). In the UK, media reporting suggests that 7% of men and 10% of 
women are trying carbohydrate-restricted diets (2), similar to data from Finland (3).  
 
The Active ‘Low-Carber’ Forums online survey (n=3134) reported that only 50% of 
respondents had support from their doctors, while 6% reported that their doctors did not 
encourage them, despite achieving weight loss. Online support forums were the most 
important source of information for 60% of the respondents, while 75% reported that 
government websites/publications were not important to them (4).  
 
Although a topic of scientific and public debates, extensive and rigorous evidence review 
finds no clear evidence from systematic reviews and meta-analyses of randomised 
controlled trials (RCT) for superiority from either high- or low-carbohydrate diets for weight 
control or for diabetes care (5-8). Most clinical guidelines allow flexibility over carbohydrate 
(CHO) content, to suit personal preference, but the role of high CHO foods as sources of 
micronutrients appears rather neglected in this debate (9, 10). Very limited previous 
evidence has suggested that micronutrient content and adequacy may be compromised 
(11). Restricting consumptions of CHO-rich foods such as wholegrains, cereals and fruits 
might reduce consumptions of B-vitamins, minerals and antioxidant nutrients, potentially 
risking deficiencies. The present systematic review has evaluated up-to-date published 
literature to assess the reported impacts of carbohydrate-restricted diet on micronutrient 
intake and micronutrient status. 
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METHODS 
This systematic review was conducted following a protocol registered in PROSPERO, 
registration number CRD42018085483 and it has been reported in accordance to the 
Preferred Reporting Items of Systematic Reviews and Meta-analyses (PRISMA) guideline 
(12).  
 
Search and information source  
A systematic literature search was conducted in electronic databases as following Web of 
Science Core Collection, Medline (OVID), EMBASE (OVID), Scopus, and Cochrane Central 
Register of Controlled Trials (CENTRAL); and ClinicalTrials.gov for trial registry record until 
October 2017, for initial searching. Having established the methodological approach, we 
updated search for Web of Science Core Collection, Medline (OVID), EMBASE (OVID), and 
Scopus databases in October 2018. We also searched for additional articles from reference 
lists of included full-texts and consulted experts in the field for relevant articles.  
 
Search limit of English language and human studies were applied. Search terms as free 
texts and MeSH terms related to carbohydrate-restricted diet and micronutrient intakes or 
statuses were used, including the following micronutrients found in CHO rich foods: 
thiamine, riboflavin, niacin, folate, cobalamin, zinc, magnesium, selenium and iron. Full 
search strategy for Medline is available online (Supplemental Table S1). 
 
Eligibility criteria 
Papers were included if they reported micronutrient intakes and/or status in adult participants 
(≥ 18 years) who have followed carbohydrate-restricted diet as either being assigned to 
carbohydrate-restricted diet intervention or being identified in observational studies. The 
study designs allowed any intervention studies (either randomised or non-randomised 
controlled trials), cohort, cross-sectional or case-control studies. Carbohydrate-restricted 
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diets included the Atkins diet, the Zone diet, the ‘paleolithic’ diet, ketogenic diets, or a 
prescribed carbohydrate-restricted diet as stated by the authors of the published studies. 
Papers were excluded if the study included a co-intervention (such as drug, or exercise 
administered alongside carbohydrate-restricted diet); subjects <18 years old; did not report 
micronutrient intakes and/or status in each diet arm (for intervention studies). 
 
Study selection and data extraction 
All records retrieved from each database were exported to EndNote (EndNote X8, Thomson 
Reuters, New York, USA). After duplicates removal, two reviewers, CC and DG, 
independently screened titles, abstracts and full-texts against eligibility criteria. A third 
reviewer (EC) was consulted when there was disagreement between the two reviewers. 
Data extraction was performed in the template created using Microsoft Excel by CC and DG 
independently, and disagreements were solved by consensus and consultation with the third 
reviewer (EC). The extracted data included: authors, year, study design, participant 
characteristics, sample size, details of intervention, dietary intakes, duration of study, 
micronutrient intakes/status, and supplement use. 
 
Risk of bias assessment 
Two reviewers independently assessed the risk of bias among included studies using the 
Cochrane Risk of Bias Tool, for RCTs, which comprises of six categories: random sequence 
generation; allocation concealment; blinding of participants and personnel; blinding of 
outcome assessment; incomplete outcome data; and selective reporting. The nature of the 
trials required open intervention with no blinding of the trial participants or the investigators. 
For observational studies and non-controlled trials, the quality assessment tools for 
observational cohort and cross-sectional studies, and for before-after (pre-post) studies with 
no control group (National Institute of Health) were used respectively. Risk of bias 
assessments were conducted for micronutrient intake outcome and micronutrient status 
outcome separately. 
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Data Synthesis 
A narrative synthesis was implemented for the present systematic review, as there were 
limited numbers and high heterogeneities of studies included. Actual intakes of 
micronutrients were translated into percentages of recommended intakes according to the 
guideline of the country where the study was conducted, including UK, USA, Australia, 
Sweden, and Iceland. Changes from baseline intake of each micronutrient were calculated 
as percentage for each time-point of follow-up. Among weight loss trials, correlation 
analyses between changes in body weight and reduced intakes of each micronutrient were 
performed using Spearman’s rank correlation. 
 
RESULTS 
A total of 595 records was retrieved from literature searching and 62 records from additional 
sources. After duplicates removal, 533 records were screened on the basis of title and 
abstract by two researchers independently, resulting in 52 full-texts to be assessed against 
the inclusion and exclusion criteria. A total of ten studies met the eligibility including seven 
RCTs, two non-controlled clinical trials and one cross-sectional study (Figure 1). Excluded 
full-texts with reasons are shown in Supplemental Table S2. 
 
Risk of bias and quality assessment 
The risk of bias of included RCTs is shown in Table 1 (including Supplemental Table S3-4 
for detailed assessment) for micronutrient intakes and status; all studies were of low risk of 
bias. The blinding of the outcome assessors was judged as low risk of bias for all RCTs, as 
the outcomes are objective (both dietary intakes and plasma/urine biomarkers of 
micronutrients). Two RCTs were judged as at high risk of attrition bias due to substantial 
dropout rate (i.e. ≥20%). Two non-controlled trials of Atkins and Atkins-style diets met 9/10 
items of the quality assessment tool for pre-post studies; and a cross-sectional study met 6/8 
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items of the quality assessment tools for observational cohort and cross-sectional studies. 
These three studies were also judged as low risk of bias (Supplemental Table S5-6).  
 
Study characteristics 
Among clinical trials, the Atkins and Atkins-style diets were used in five RCTs and two non-
controlled trials; and the ‘paleolithic’ diet in two RCTs. Durations of intervention ranged from 
2 weeks to 24 months (104 weeks). All trials with Atkins-style diet (n=7) were conducted in 
adults with overweight and obesity, but neither established cardiovascular diseases nor 
diabetes mellitus. One Atkins-style diet trial included patients with high liver fat content. Two 
studies with the ‘paleolithic’ diets were conducted in self-reported healthy women and 
postmenopausal women. Sample sizes ranged from 10 to 293 participants (Table 1).  
 
Eight clinical trials aimed primarily to assess the effects of carbohydrate-restricted diet for 
weight loss and body composition, either with or without comparison to other weight loss 
diets (6 Atkins-style diets, 2 ‘paleolithic’ diets). Of these, one crossover RCT additionally 
assessed effects of Atkins diet on antioxidant vitamin status. One other non-controlled trial 
assessed the effect of ‘isocaloric’ carbohydrate-restricted diet on liver fat content and gut 
microbiota without body weight loss in patients with high liver fat content. There was no 
report of clinically diagnosed micronutrient deficiency among the included trials. Only one 
trial prescribed multivitamins supplement to the participants, with one other trial reporting the 
number of participants who started taking supplements after the carbohydrate-restricted diet. 
The rest of the included studies did not report on supplement use (Table 1). 
 
Four clinical trials provided diet books for participants to follow without any further 
instructions, while three clinical trials conducted counselling sessions, two short-term trials 
(2-4 weeks) provided all foods and drinks to their participants. A cross-sectional study of 
people voluntarily following carbohydrate-restricted diet did not report on the sources of their 
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carbohydrate-restricted diet information. Amount of CHO contributing to total energy intake 
varied among studies ranging from 4% to 34%. However, mean CHO intakes met pre-
specified CHO contents (adherence) in only 4/6 trials during 4 weeks to 3 months treatment 
time (Table 2).  
 
Changes in body weight and energy intake in the included studies 
Of eight weight loss trials, reported energy intakes per day decreased by approximately -300 
to -1000 kcal (median -656 kcal), [-1255 kJ to -4184 kJ; median -2745 kJ], and body weight 
changes ranged from -3.2 to -8.5 kg over 2 weeks to 24 months. In contrast, a study of 
‘isocaloric’ carbohydrate-restricted diet that aimed to maintain body weight reported an 
increase in reported energy intake of +880 kcal but demonstrated mean weight loss of -1.9 
kg (Table 3-4). 
 
Micronutrient intakes 
Micronutrient intakes among the studies included were assessed by self-reported dietary 
records (n=6), and 24-hr dietary recalls (n=2), while two of the studies provided all foods and 
drinks to their participants (Table 1). Table 3 and 4 show amounts of micronutrient intakes 
per day, percentage of recommended intake in the country where the study was conducted, 
and the changes from baseline of each micronutrient in included studies. Numbers of studies 
that reported micronutrients are as following: thiamine (n=6), folate (n=8), vitamin B12 (n=4), 
vitamin C (n=9), vitamin A (n=7), beta-carotene (n=4), vitamin E (n=6), calcium (n=7), 
magnesium (n=6), iron (n=6), iodine (n=2), zinc (n=5), and selenium (n=4).  
 
Among all weight loss trials (reduced energy intake; assessed by dietary records and/or 24-
hr recalls), there were reductions (from baseline) in thiamine intake (-35 to -68%, n=5), folate 
(-15 to -71%, n=6), calcium (-13 to -63%, n=5), magnesium (-9 to -54%, n=4), iron (-13 to -
57%, n=4), and iodine (-47%, n=1). All these micronutrients were also lower than the 
country-specific recommended intakes and accounted for 35 to 80% of recommended 
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intake. One single-arm trial with ‘isocaloric’ intake (all food provided) in patients with high 
liver fat showed a significant increase in thiamine, but reductions in magnesium and iodine 
intakes, while no significant changes for folate, calcium or iron (Table 3 and 4). When 
comparing to control diets, most of the RCTs showed that participants in carbohydrate-
restricted diet group had lower intakes of thiamine, folate, calcium, magnesium, iron and 
iodine (Table 5).  
 
Approximately 30% increase in vitamin B12 intake was reported in clinical trials of 4 to 8-
week Atkins diet compared to baseline, two- to six-fold higher than the recommended intake. 
Atkins diet trials reported reduced vitamin C intake, by -3 to -71% from baseline, but the 
‘paleolithic diet’ showed a significant increase in vitamin C intake by 57%. Similarly, Atkins 
diet trials (n=6) showed inconsistent findings regarding vitamin A, E, and beta-carotene 
intakes, while a single ‘paleolithic diet’ trial showed increases in these micronutrients 
(vitamin A, E, and beta-carotene intakes) by +100%, +46%, and +167% respectively (Table 
3). Intakes of zinc and selenium did not change markedly; the intakes at baseline and at the 
end of trials were both above recommended intakes (Table 4). Dietary data for vitamin B12, 
A, C, E, beta-carotene, zinc and selenium among the included studies were assessed by 
either self-reported dietary records, 24-hr recalls, or analysis of all foods provided by 
researchers. 
 
Correlations between changes in body weight and micronutrient intakes 
There were strong correlations between amount of weight loss (kg) and actual intakes of 
thiamine (rho=0.83, p=0.167), magnesium (rho=0.95, p=0.051) and iron (rho=0.95, p=0.051). 
As percentage of Reference Nutrient Intake (%RNI), there were only strong correlations 
between weight loss and %RNI of magnesium (rho=0.92, p=0.026) and iron (rho=0.82, 
p=0.089). 
 
Micronutrient adequacy 
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No case of clinical micronutrient deficiency was reported. Only one RCT by Gardner et al. 
reported micronutrient adequacy by showing the proportion of participants whose intakes 
were below estimated average requirement (EAR) after 8 weeks on an Atkins diet for weight 
loss. Three non-consecutive 24-hr dietary recalls were used in this study. Intakes of 
thiamine, folate and vitamin C all fell below EAR in approximately 50% of participants, 70% 
for magnesium and 30% for iron. Importantly, there was a three-fold increase in the 
proportion of participants who had iron intakes below EAR at the end of the Atkins diet trial 
(from 3% to 32% of participants). 
 
Micronutrient status 
Measure of micronutrient status were reported only in four studies, including Atkins diet 
(n=1), paleolithic diet (n=2), and ‘isocaloric’ carbohydrate-restricted diet (n=1) for folate, 
vitamin A, carotenoids, vitamin E and iodine (Table 6). Serum and red blood cell (RBC) 
folate increased after 2 weeks of ‘isocaloric’ carbohydrate-restricted diet (+9 nmol/L) and 4 
weeks of a ‘paleolithic’ diet (+90 nmol/L) respectively, which are in disagreement with 
reported folate intakes (Table 3). The Atkins diet resulted in an increase in plasma vitamin C 
concentration, but reductions (-2 to -40% from baseline) in plasma retinol, carotenoids, and 
α-tocopherol. In contrast, the ‘paleolithic’ diet reported increases in plasma lycopene, α- and 
β-carotenes (Table 6).  
 
Iodine status was reported in only one RCT showing a significant reduction in median 24-
hour urine iodine concentration after a ‘paleolithic’ diet at both 6 months (36 µg/L) and 2 
years (57 µg/L), compared to baseline (68 µg/L); one to two-fold lower than the control diet 
(no change through the study, 70 µg/L) (Table 6). Importantly, there was a rise in proportion 
of women with urine iodine concentration <50 µg/L, which is the internationally agreed cut-off 
for moderate iodine deficiency, from 15% at baseline to 73% at 6 months on the ‘paleolithic’ 
diet (Table 6). 
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DISCUSSION 
Most carbohydrate-restricted diets are used for weight control.  Losing weight requires an 
energy restricted (i.e. macronutrient-restricted) diet for a significant period of time.  However, 
the body still requires adequate micronutrient intake to maintain normal metabolic function. If 
the weight loss diet is not well designed nutritionally, micronutrient insufficiencies can 
develop.  The present paper is a systematic review of published evidence, up to October 
2018, on the impact of carbohydrate-restricted diets on micronutrient intakes and status. 
Although rather few published studies on carbohydrate-restricted diets have reported their 
effects on micronutrients, we have identified some consistent patterns of reduced 
micronutrient intakes, and to levels lower than control-diets, when people follow diets which 
limit CHO-rich foods.  A variety of carbohydrate-restricted diets were examined, mostly 
primarily aiming for weight control.  Given the lack of consistent difference in weight loss, 
compared to higher CHO diets (6, 13, 14), these findings might provide grounds to prefer 
weight-control diets which do not excessively restrict CHO more than other macronutrients. 
 
Intakes of thiamine, folate, magnesium, calcium, iron and iodine all decreased after following 
any types of carbohydrate-restricted diet (Figure 2). This probably reflects the fact that CHO-
rich staple foods are a good source of vitamins and minerals, either naturally presented or 
being fortified, and for some they usually form the main sources to reach dietary reference 
values (DRVs). For example, the DRV (UK) of thiamine for a healthy adult man is 1 mg/day.  
This would be met by about 100g of commercial breakfast cereal, 400g of wholemeal 
breads. Not all CHO-rich foods are such rich source of thiamine, thus to reach the DRV 
would require about 500g of baked potato, but this compares with 1000g of beef, or 1250 g 
of boiled eggs, or 5000g of cheese (15). Although iodine is not a nutrient acquired from 
CHO-rich foods, both Atkins and ‘paleolithic’ diets exclude milk/dairy from the diets leading 
to lower iodine intake. Our systematic review showed that both iodine intake and iodine 
status (urinary biomarker) were reduced after following a ‘paleolithic’ diet (23, 31). In the UK, 
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bread and fortified breakfast cereals, milk and milk products, and vegetable including 
potatoes are the top three food-groups as sources of the vitamins and minerals (16), which 
are reported to be reduced on carbohydrate-restricted diets.  
 
The reduced intakes with carbohydrate-restricted diets in studies reviewed here could have 
important clinical consequences. There have been case reports of severe, potentially life-
threatening, thiamine deficiency from following extreme or prolonged carbohydrate-restricted 
diets. Bilateral optic neuropathy was reported in two patients who followed a prolonged 
CHO-restricted diet (17) and Wernike’s encephalopathy with cardiac beriberi was reported in 
a young man with obesity who cut out all breads, cereal and pasta for several months (18). 
Given that weight loss may promote reproductive function in women with overweight/obesity, 
inadequate intake of folate and iodine in women of child-bearing age both increase risk of 
foetal maldevelopment, and iron deficiency is already frequent in young women (19, 20).  
Increased risk by 17-22% of type 2 diabetes has been reported with low magnesium 
consumption (21, 22). 
 
For other vitamins, different advice between specific carbohydrate-restricted diets regarding 
fruits and vegetables intake probably explains the variable effects on some micronutrients. 
Reductions in carotenoid intakes and plasma concentrations were reported after an Atkins 
diet (24), while there were increases in carotenoid intakes and plasma concentrations after a 
‘paleolithic’ diet (23). The ‘paleolithic’ diet (23) also showed an increase in vitamin C intake, 
reflecting advice to consume more fruits than typical Atkins diets, which mostly showed 
reductions in vitamin C intakes (25, 26) (Figure 2). However, one trial with a modified Atkins 
diet showed an increase in plasma vitamin C concentration, probably because fruit juice was 
included in the meals provided (24). 
 
Despite reduced intake of folate, serum and RBC folate increased following an ‘isocaloric’ 
carbohydrate-restricted diet and one ‘paleolithic’ diet. This is proposed to be due to a 
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carbohydrate-restricted diet induced increment in folate-producing gut bacteria as 
demonstrated in the study by Mardinoglu et al.(27) or it may reflect a limitation in the food 
composition database used (23). The intakes of some micronutrients (status not reported), 
specifically B12, zinc and selenium, did consistently increase after carbohydrate-restricted 
diet – however, intakes were adequate at baseline. 
 
Limitations and strength 
It was disappointing, but perhaps interesting given the amount of media interest, that so few 
of the many studies on carbohydrate-restricted diets have reported micronutrient intakes or 
status. The lack of reporting of measured micronutrient status is concerning, given the 
potential for serious deficiencies, and because there are always questions about the 
reliability of dietary assessment methods to report intakes. Two out of 10 included studies 
used the memory-based 24-hour dietary recall, while the rest used a prospective approach 
(dietary record) and/or supplied all foods and drinks to participants. Only four out of 10 
studies employed an objective biomarker measurement for at least one micronutrient. 
 
There is a wide variety of what people consider to be a 'low-carbohydrate diet', as low as 20-
50 g of carbohydrate per day or up to 40-45% of total energy intake as seen in many low-
carbohydrate diet papers (6, 7, 23, 25).  For people who are not wishing to lose weight, 
under 50 g of carbohydrate per day leaves a large (somewhat less practical) amount of 
calories to be derived from non-CHO sources. The compositions of control diets in RCTs 
also varied in macronutrient contents.  
 
Only one trial reported proportion of participants below EAR, but this could be more clinically 
meaningful if all studies could have reported on proportion below lower reference nutrient 
intakes. Another important point relates to the between-country variation in terms of 
recommended intake, which would lead to different apparent dietary adequacy for some 
micronutrients. For example, the UK RNI for folate and vitamin C are 200 mcg and 40 mg 
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per day while these are 400 mcg and 90 mg for USA. If the USA recommended intakes were 
used for all studies, the numbers of inadequate intakes reported could be greater in some 
other countries. 
 
Despite the Atkins diet book recommending dietary supplements, most of the included 
studies did not report on supplement use causing difficulties in estimating of how significant 
the problem of inadequacy is. There is no guideline on the use of micronutrient 
supplementation while on energy restricted diets.  The present systematic review has found 
frequent and consistent reductions in intake or status, such that micronutrient 
supplementation might be recommended routinely with carbohydrate-restricted diets.   
 
Conclusion 
This study has used rigorous systematic review methodology to establish a rather consistent 
finding of multiple micronutrient inadequacy in free-living participants following carbohydrate-
restricted diet. All included studies seem to be at low risk of bias.  Future research should 
report on micronutrient status as well as dietary intakes, to inform not only the benefits of the 
intervention, but also the risk of micronutrient inadequacies, which could help 
readers/practitioners’ decision-making.  There is a case for recommending routine use of 
micronutrient supplementation with carbohydrate-restricted diets.  
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Table Legends: 
Table 1. Characteristics of included studies (n=10) 
Values are presented as mean ± SD unless otherwise indicated. 
RCT, randomised controlled trial; CRD, carbohydrate-restricted diet; BMI, bod mass index; 
CVD, cardiovascular disease; MCD, moderate carbohydrate diet; N/A, not applicable 
 
Table 2. Mode of diet delivery, prescribed carbohydrate-restricted diets, and 
macronutrient intakes in the studies included. 
Values are presented as mean ± SD unless otherwise indicated. 
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; CRD, carbohydrate-
restricted diet; CHO, carbohydrate; Pro, protein; E, energy; SFA, saturated fatty acids; OWL, 
ongoing weight loss; LFD, low fat diet; LEARN, Lifestyle, Exercise, Attitudes, Relationships, 
Nutrition; AGHE, Australian Guideline to Healthy Eating; NNR, Nordic Nutrition 
Recommendations; MTV/MTM, multivitamins/multimineral; N/A, not applicable 
a no SD was reported. 
 
Table 3. Actual intakes of vitamins, percentage of recommended intakes and changes 
from baseline. 
Values are expressed as mean (SD) unless otherwise indicated.  
M, men; W, women; wk, week; mo, month; BW, body weight; EI, energy intake; RI, 
recommended intake. 
a cross-sectional study, b values are median (Interquartile range). 
 
Table 4. Mineral intakes, percentage of recommended intakes and changes from 
baseline. 
Values are expressed as mean (SD) unless otherwise indicated.  
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M, men; W, women; wk, week; mo, month; BW, body weight; EI, energy intake; RI, 
recommended intake. 
a cross-sectional study, b values are median (Interquartile range). 
 
Table 5 Micronutrient intakes following carbohydrate-restricted diets compared to 
control diets. 
Values are mean (SD) unless otherwise indicated.  
CRD, carbohydrate-restricted diet; LFD, low-fat diet; RNI, reference nutrient intake; AGHE, 
Australian Guideline Healthy Eating. 
* p<0.05, ** p<0.01, *** p<0.001 compared between groups. 
a no SD reported. 
b no statistical comparison between groups 
c P-values obtained from ANOVA, pairwise comparisons were significantly different (Tukey’s 
Studentised range test) 
d P-values for mean difference of change (end - baseline) between groups   
 
Table 6. Plasma and urine biomarkers of micronutrients 
Values are mean ± SD unless otherwise indicated.  
CRD, carbohydrate-restricted diet; UIC, urine iodine concentration; UIE, urine iodine 
excretion; IQR, interquartile range; ns, not significant 
a no SD reported 
b p-value compared to baseline 
c p-value from the longitudinal analysis compared to baseline 
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Legends for Figures 
Figure 1. Study selection flow diagram.  
WoS, Web of Sciences; CENTRAL, Cochrane Central Register of Controlled Trials; CRD, 
carbohydrate-restricted diet. 
 
Figure 2. Percentage of changes from baseline intakes at the end of each study by 
micronutrients 
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Table 1. Characteristics of included studies (n=10) 
Author/ 
country Study design Study population Age, BMI 
Primary outcome 
of studies 
Duration of 
interventions 
Dietary assessment 
methods Supplement use 
Overall risk 
of bias 
Miller 2003 
USA (28) 
Single arm 
clinical trial 
9 men and 9 women, 
overweight & obesity, 
without clinical 
cardiovascular disease 
and diabetes. 
Age 39.8 ± 8 y 
BMI 36.4 ± 6.5 
kg/m2 
Weight loss and 
dietary intake 
4 weeks 3-day dietary record Multivitamin daily 
provided by a 
research team 
Low 
Brehm 2003 
USA (29) 
Parallel RCT 53 women with 
obesity, without clinical 
cardiovascular disease 
and diabetes. 
(completers=42) 
Age 44.2 ± 7 y 
BMI 33.2 ± 1.8 
kg/m2 
Weight loss 6 months 3-day weighed food 
record 
Not reported Low 
Truby 2008 
UK (26) 
Parallel RCT 293 men and women, 
overweight & obesity, 
without clinical 
cardiovascular disease 
and diabetes.  
(completers=240) 
Age 40 ± 10 y 
BMI 32 ± 3 kg/m2 
Weight loss 6-month trial but 
dietary intake 
reported only over 
the first 2 months. 
7-day estimated dietary 
record 
Not reported Low 
Gardner 2010 
USA (25) 
Parallel RCT 311 women, 
overweight & obesity, 
without clinical 
cardiovascular disease 
and diabetes. 
(completers=291) 
Age 42 ± 5 y 
BMI 32 ± 4 kg/m2 
Weight loss 12-month trial but 
dietary intake 
reported only over 
the first 8 weeks. 
3 separate, non-
consecutive, 24-hr 
dietary recalls 
Voluntarily taking 
MTV/MTM, n=3; 
Calcium, n=3. 
Low 
Johnston 
2011 
UK (24) 
Cross-over 
RCT 
16 men, overweight & 
obesity without clinical 
cardiovascular disease 
and diabetes. 
Age 55 ± 14 y 
BMI 36 ± 6 kg/m2 
Weight loss and 
antioxidant 
micronutrient 
status 
4 weeks of CRD 
crossover with 4 
weeks of MCD. 
Research staff 
supplied all foods and 
drinks. 
Not reported Low 
Bazzano 2014 
(30) 
Parallel RCT 148 men and women 
without clinical 
cardiovascular disease 
and diabetes. 
(completers=119) 
Age 45.8 + 9.9 y 
BMI 35.2 + 3.8 
kg/m2 
Weight loss 12 months 2 days 24-hr dietary 
recalls 
Not reported Low 
Genoni 2016 
Australia (23) 
Parallel RCT 42 healthy women 
(completers=39) 
Age 47 ± 13 y 
BMI 27 ± 4 kg/m2 
Body weight 
change, CVD risk 
factors 
4 weeks 3-day weighed food 
record 
Not reported Low 
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Manousou 
2018 
Sweden (31) 
Parallel RCT 70 women, 
postmenopausal, 
overweight & obesity 
without clinical 
cardiovascular disease 
and diabetes. 
(completers=49) 
Age 60 ± 6.3 y 
BMI 32.6 ± 3.4 
kg/m2 
Weight loss and 
body composition 
24 months 4-day estimated dietary 
record 
Not reported Low 
Mardinoglu 
2018 (27) 
Single arm 
clinical trial 
10 adults (8 men) with 
high liver fat content 
Age 53.7±3.65 y 
BMI 34.1±1.2 kg/m2 
Liver fat loss 2 weeks All food provided Not reported Low 
Elidottir 2016 
Iceland (32) 
Cross-
sectional study 
54 adults voluntarily 
following CRD 
Age 43 ± 11 y 
BMI 30 ± 4 kg/m2 
To assess dietary 
intakes and CVD 
risk factors 
N/A 3-day weighed food 
record 
Not reported Low 
Values are presented as mean ± SD unless otherwise indicated. 
RCT, randomised controlled trial; CRD, carbohydrate-restricted diet; BMI, bod mass index; CVD, cardiovascular disease; MCD, moderate carbohydrate diet; N/A, not applicable 
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Table 2. Mode of diet delivery, prescribed carbohydrate-restricted diets, and macronutrient intakes in the studies included. 
Author/ 
country Mode of diet delivery Pre-specified CRD Baseline 
CRD 
(Intermediate) 
CRD 
(Last time-point) 
Comparator 
(Last time-point) 
Miller 2003 
USA (28) 
A copy of Dr Atkins’ New 
Diet Revolution book was 
provided. 
<20 g CHO/day, ad libitum for fat. Add 
5 g CHO/day up to 30 g/day during 
ongoing weight loss weeks. 
Baseline 
E 2481 ± 723 kcal 
(10.4 ± 3 MJ) 
CHO 43%, Pro 16% 
Fat 41% 
Induction 2 weeks 
E1400 ± 472 kcal 
(5.9 ± 2 MJ) 
CHO 21 g (6%) 
Pro 29%, Fat 64% 
OWL: 2 weeks 
E 1558 ± 490 kcal 
(6.5 ± 2 MJ) 
CHO 24 g (6%) 
Pro 29%, Fat 64% 
N/A 
Brehm 2003 
USA (29) 
Dietitians led group 
sessions for participants to 
follow the Atkins diet. 
<20 g CHO/day, ad libitum for fat. After 
2 weeks, increase CHO to 40-60 g/day. 
Baseline a 
E 1608 kcal (6.7 MJ) 
CHO 47%, Pro 16% 
Fat 37% (SFA 12.4%) 
3 months a 
E1156 kcal (4.8 MJ) 
CHO 41 g (15%) 
Pro 28% 
Fat 57% (SFA 21%) 
6 months a 
E 1302 kcal (5.5 MJ) 
CHO 97 g (30%) 
Pro 23% 
Fat 46% (SFA 17%) 
LFD 6 months a 
E 1247 kcal (5.2 MJ) 
CHO 53%, Pro 18% 
Fat 29% (SFA 11%) 
Truby 2008 
UK (26) 
A copy of Dr Atkins’ New 
Diet Revolution book was 
provided. 
Participants were asked to follow the 
book. Ad libitum 
Baseline 
E 2283 ± 643 kcal 
(9.6 ± 2.7 MJ) 
CHO 42%, Pro 16% 
Fat 37% 
2 months 
E 1627 ± 551 kcal 
(6.8 ± 2.3 MJ) 
CHO 12%, Pro 28% 
Fat 57%, Alcohol 3% 
Not reported Control 2 months 
E 1899 ± 624 kcal 
(8 ± 2.6 MJ) 
CHO 42%, Pro 16% 
Fat 37%, Alcohol 5% 
Gardner 
2010 
USA (25) 
A copy of Dr Atkins’ New 
Diet Revolution book was 
provided. 
Induction phase <20 g CHO/day, 
duration depended on participants. 
Ongoing phase CHO <50 g/day. 
Baseline 
E 1929 ± 509 kcal 
(8.1 ± 2.1 MJ) 
CHO 46%, Pro 17% 
Fat 36% (SFA 12%) 
8 weeks 
E 1373 ± 340 kcal 
(5.7 ± 1.4 MJ) 
CHO 58 g (17%) 
Pro 28% 
Fat 55% (SFA 20%) 
Not reported LEARN 8 weeks 
E 1478 ± 444 kcal 
(6.2 ± 1.9 MJ) 
CHO 49%, Pro 20% 
Fat 30% (SFA 10%) 
Johnston 
2011 
UK (24) 
Research staff supplied all 
foods and drinks for a very 
low carbohydrate diet. 
Low-carb, hi-protein: 4% CHO, 30% 
Protein, 66% Fat.  
70% of energy requirement. 
Baseline a 
E 2744 kcal (11.5 MJ) 
CHO 52%, Pro 12% 
Fat 38% (SFA 13%) 
N/A 4 weeks a 
E 1906 kcal (8 MJ) 
CHO 22 g (4%) 
Pro 29% 
Fat 67% (SFA 21%) 
N/A 
Bazzano 
2014 (30) 
Dietitian led counselling 
sessions. A handbook of 
diet recipes, menu, food & 
shopping lists, meal planner 
was provided. 1 meal 
replacement per day was 
provided.  
<40 g CHO/day, no specific energy 
goal. Participants also received 
education on SFA, MUFA, and trans 
fats, with emphasis on the benefits of 
MUFA and to limit trans fats. 
Baseline 
E 1998 ± 740 kcal 
(8.4 ± 3.1 MJ) 
CHO 48%, Pro 17% 
Fat 33% (SFA 11%) 
3 months 
E 1258 ± 409 kcal 
(5.3 ± 1.7 MJ) 
CHO 97 g (29%) 
Pro 26% 
Fat 43% (SFA 14%) 
6 months 
E 1324 ± 537 kcal 
(5.5 ± 2.2 MJ) 
CHO 93 g (28%) 
Pro 26% 
Fat 44% (SFA 13%) 
12 months 
E 1448 ± 610 kcal 
(6.1 ± 2.6 MJ) 
CHO 127 g (34%) 
Pro 24% 
Fat 41% (SFA 13%) 
 
LFD 12 months 
E 1527 ± 522 kcal 
(6.4 ± 2.2 MJ) 
CHO 54%, Pro 19% 
Fat 30% (SFA 9%) 
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Genoni 2016 
Australia 
(23) 
A copy of the Paleo Diet 
book was provided. 
Advise for lean meats, fish, egg, nuts, 
fruits and vegetables, almond milk.  
No corn, white potatoes, and legumes. 
No grains, cereals and dairy products. 
Ad libitum 
Baseline 
E 1864 ± 461 kcal 
(7.8 ± 1.9 MJ) 
CHO 39%, Pro 21% 
Fat 34% (SFA 12%) 
N/A 4 weeks 
E 1414 ± 347 kcal 
(5.9 ± 1.5 MJ) 
CHO 103 g (28%) 
Pro 27% 
Fat 40% (SFA 12%) 
AGHE 4 weeks 
E 1591 ± 412 kcal 
(6.7 ± 1.7 MJ) 
CHO 41%, Pro 22% 
Fat 33% (SFA 12%) 
Manousou 
2018 
Sweden (31) 
Participants attended group 
session with diet and 
cooking practice for a 
Paleolithic diet. 
30% CHO, 30% Pro, 40% Fat. Advise 
for lean meats, fish, egg, nuts, fruits 
and vegetables. No cereals, beans, 
refined fat & sugar, salt, soft drinks and 
bakery products. Ad libitum 
Baseline 
E 1993 ± 412 kcal 
(8.3 ± 1.7 MJ) 
CHO 44%, Pro 17% 
Fat 34% 
6 months 
E 1590 ± 327 kcal 
(6.7 ± 1.4 MJ) 
CHO 29%, Pro 24% 
Fat 44% 
24 months 
E 1531 ± 436 kcal 
(6.4 ± 1.8 MJ) 
CHO 31%, Pro 23% 
Fat 42%  
NNR 24 months 
E 1716 ± 279 kcal 
(7.2 ± 1.2 MJ) 
CHO 43%, Pro 17% 
Fat 35% 
Mardinoglu 
2018 (27) 
Research staffs supplied all 
foods and drinks 
‘Isocaloric’ CRD, did not aim for weight 
loss. 
Baseline 
E 2235 ± 221 kcal 
(9.4 ± 0.9 MJ) 
CHO 40%, Pro 20% 
Fat 40% (SFA 14%) 
N/A 2 weeks 
E 3115 ± 410 kcal 
(13 ± 1.7 MJ) 
CHO 4%, Pro 24% 
Fat 72% (SFA 10%) 
N/A 
Elidottir 2016 
Iceland (32) 
Voluntary adherence to 
CRD. 
N/A, cross-sectional study N/A N/A E 1928 ± 534 kcal 
(8.1 ± 2.2 MJ) 
CHO 10%, Pro 23% 
Fat 66% (SFA 26%) 
N/A 
Values are presented as mean ± SD unless otherwise indicated. 
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; CRD, carbohydrate-restricted diet; CHO, carbohydrate; Pro, protein; E, energy; SFA, saturated fatty acids; OWL, ongoing weight 
loss; LFD, low fat diet; LEARN, Lifestyle, Exercise, Attitudes, Relationships, Nutrition; AGHE, Australian Guideline to Healthy Eating; NNR, Nordic Nutrition Recommendations; MTV/MTM, 
multivitamins/multimineral; N/A, not applicable 
a no SD was reported. 
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Table 3. Actual intakes of vitamins, percentage of recommended intakes and changes from baseline. 
    
 Thiamine    Folate    B12 
  
 Vitamin C   
 
Time 
points 
BW 
loss 
(kg) 
EI 
chan
ge 
(kcal) 
EI 
chan
ge 
(MJ) 
Intake (mg) %RI 
Baselin
e 
change 
(%) 
 Intake (µg) %RI 
Basel
ine 
chan
ge 
(%) 
 Intake 
(µg) %RI 
Baselin
e 
change 
(%) 
 
Intake 
(mg) %RI 
Baselin
e 
change 
(%) 
Miller (M) baseline 
  
 2.8 (2.1) 233 
  
496 (446) 124 
  
8 (6.3) 333 
 
 90 (77) 100  
2003 US 2 wk -3.8 -1081 -4.5 3.9 (8.7) 325 +39 
 
142 (62) 36 -71 
 
7.6 (6.4) 317 -5  31 (27) 34 -66 
 
4 wk -5.3 -923 -3.9 0.9 (0.3) 75 -68 
 
191 (56) 48 -62 
 
9 (3.3) 375 +13  26 (22) 29 -71 
Miller (W) baseline 
  
 1.5 (0.3) 136 
  
209 (65) 52 
  
4.3 (1.3) 179 
 
 84 (46) 112  
2003 US 2 wk -3.8 -1081 -4.5 0.9 (1.1) 82 -40 
 
236 (279) 59 +13 
 
7 (4.7) 292 +63  48 (48) 64 -43 
 
4 wk -5.3 -923 -3.9 0.8 (0.4) 73 -47 
 
177 (105) 44 -15 
 
5.6 (2.8) 233 +30  41 (33) 55 -51 
Brehm baseline 
  
 - - - 
 
155.1 39 
  
- - -  70.3 94  
2003 US 3 mo -7.6 -452 -1.9 - - - 
 
139.7 35 -10 
 
- - -  35.7 48 -49 
 
6 mo -8.5 -306 -1.3 - - - 
 
195.9 49 +26 
 
- - -  58.5 78 -17 
Truby baseline 
  
 - 223 (186) 
   
139 (49) 
  
- - -   224 (126)  
2008 UK 2 mo -5.2 -656 -2.7 - 146 (49) -35 
  
93 (44) -33 
 
- - -   132 (104) -41 
Gardner baseline 
  
 1.6 (0.5) 146 
  
535 (207) 134 
  
4.9 (4.3) 204 
 
 94 (59) 125  
2010 US 2 mo -4.3 -556 -2.3 0.9 (0.4) 82 -44 
 
329 (141) 82 -39 
 
6.6 (7.9) 275 +35  66 (39) 88 -30 
Johnston baseline 
  
 - - - 
 
- - - 
 
- - -  153 383  
2011 UK 4 wk -6.8 -838 -3.5 - - - 
 
- - - 
 
- - -  148 370 -3 
Bazzano baseline 
  
 - - - 
 
410 (190) 103 
  
- - -  87 (60) 118  
2014 US 3 mo -5.7 -740 -3.1 - - - 
 
290 (130) 73 -29 
 
- - -  68 (45) 90 -24 
 
6 mo -5.6 -674 -2.8 - - - 
 
320 (170) 80 -22 
 
- - -  81 (55) 108 -9 
 
12 mo -5.3 -550 -2.3 - - - 
 
310 (150) 78 -24 
 
- - -  73 (68) 97 -18 
Genoni baseline 
  
 1.55 (0.6) 141 
  
396 (136) 99 
  
- - -  107 (50) 238  
2016 Aus 4 wk -3.2 -450 -1.9 0.96 (0.5) 87 -38 
 
317 (85) 79 -20 
 
- - -  168 (84) 373 +57 
Mardinogl
u 
baseline 
  
 1.64 (0.4) 126 
  
365 (168) 122 
  
11 (12) 567 
 
 142 (83) 190  
 2018 
Sweden 
2 wk -1.9 +880 +3.7 2.9 (0.5) 223 +77 
 
345 (16) 115 -5 
 
12 (0.7) 607 +7  154 (6) 206 +8 
Elidottir a, 
b 
Men - - - 1.6 (1.4) 123 -  319 (295) 106 -  7 (5) 350 -  53 (77) 71 - 
2016 
Iceland 
Women - - - 1.0 (1.3) 91 -  275 (335) 92 -  7 (4) 350 -  76 (92) 101 - 
Values are expressed as mean (SD) unless otherwise indicated. M, men; W, women; wk, week; mo, month; BW, body weight; EI, energy intake; RI, recommended intake. 
a cross-sectional study, b values are median (Interquartile range). 
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Table 3. Actual intakes of vitamins, percentage of recommended intakes and changes from baseline (continued). 
    
 Vitamin A    Beta- Carotene   Vitamin E 
  
 
Time 
points 
BW 
loss 
(kg) 
EI change 
(kcal) 
EI 
change 
(MJ) 
Intake (µg) %RI 
Baseline 
change 
(%) 
 Intake (µg) %RI 
Baseline 
change 
(%) 
 Intake (mg) %RI Baseline change (%) 
Miller (M) baseline 
  
 1553 (1733) 173 
  
- - - 
 
15 (16) 100 
 
2003 2 wk -3.8 -1081 -4.5 513 (238 57 -67 
 
- - - 
 
29 (69) 193 +93  
4 wk -5.3 -923 -3.9 622 (355 69 -60 
 
- - - 
 
7.1 (2.5) 47 -53 
Miller (W) baseline 
  
 779 (387) 111 
  
- - - 
 
9.4 (3.8) 63 
 
2003 2 wk -3.8 -1081 -4.5 1023 (1094) 146 +31 
 
- - - 
 
11 (15) 71 +14  
4 wk -5.3 -923 -3.9 703 (385) 100 -10 
 
- - - 
 
7 (5) 47 -26 
Brehm baseline 
  
 - - - 
 
- - - 
 
- - - 
2003 3 mo -7.6 -452 -1.9 - - - 
 
- - - 
 
- - -  
6 mo -8.5 -306 -1.3 - - - 
 
- - - 
 
- - - 
Truby baseline 
  
 - 182 (192) 
  
- - - 
 
- - - 
2008 2 mo -5.2 -656 -2.7 - 175 (257) -4 
 
- - - 
 
- - - 
Gardner baseline 
  
 681 (289) 97 
  
- - - 
 
8.4 (4.1) 56 
 
2010 2 mo -4.3 -556 -2.3 743 (323) 106 +9 
 
- - - 
 
8.7 (4.8) 58 +4 
Johnston baseline 
  
 533 76 
  
3705 - 
  
7.2 n/a 
 
2011 4 wk -6.8 -838 -3.5 625 89 +17 
 
3778 - +2 
 
11.9 n/a +65 
Bazzano b baseline 
  
 - - - 
 
490 (1310) - 
  
- - - 
2014 3 mo -5.7 -740 -3.1 - - - 
 
890 (1990) - +82 
 
- - -  
6 mo -5.6 -674 -2.8 - - - 
 
600 (1500) - +22 
 
- - -  
12 mo -5.3 -550 -2.3 - - - 
 
420 (1420) - -14 
 
- - - 
Genoni baseline 
  
 1015 (448) 145 
  
4258 (2508) - 
  
9.8 (2.5) 140 
 
2016 4 wk -3.2 -450 -1.9 2032 (1359) 290 +100 
 
11379 (7966) - +167 
 
14.3 (7.3) 204 +46 
Mardinoglu baseline 
  
 1517 (2243) 169 
  
4116 (2503) - 
  
13.8 (4.5) 138 
 
 2018 2 wk -1.9 +880 +3.7 724 (35) 80 -52 
 
3011 (134) - -27 
 
30.9 (1.5) 309 +125 
Elidottir a,b Men - - - 956 (773) 106 -  - - -  16 (13) 160 - 
2016 Women - - - 880 (472) 126 -  - - -  17 (8) 213 - 
Values are expressed as mean (SD) unless otherwise indicated. M, men; W, women; wk, week; mo, month; BW, body weight; EI, energy intake; RI, recommended intake. 
a cross-sectional study, b values are median (Interquartile range). 
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Table 4. Mineral intakes, percentage of recommended intakes and changes from baseline. 
    
 Calcium    Magnesium    Iron 
  
 
Time 
points 
BW 
loss 
(kg) 
EI 
change 
(kcal) 
EI change 
(MJ) Intake (mg) %RI 
Baseline 
change 
(%) 
 Intake (mg) %RI 
Baseline 
change 
(%) 
 Intake 
(mg) %RI 
Baseline 
change (%) 
Miller (M) baseline 
  
 1139 (458) 114   350 (149) 83   21 (12) 263  
2003 US 2 wk -3.8 -1081 -4.5 420 (180) 42 -63  163 (61) 39 -53  9 (4) 113 -57 
 
4 wk -5.3 -923 -3.9 503 (153) 50 -56  180 (41) 43 -49  12 (3) 150 -43 
Miller (W) baseline 
  
 801 (309) 80   280 (72) 88   13 (3) 72  
2003 US 2 wk -3.8 -1081 -4.5 513 (223) 51 -36  129 (42) 40 -54  8 (2) 44 -39 
 
4 wk -5.3 -923 -3.9 517 (268) 52 -36  182 (163) 57 -35  8 (4) 44 -39 
Brehm baseline 
  
 591 59   - - -  - - - 
2003 US 3 mo -7.6 -452 -1.9 444 44 -25  - - -  - - - 
 
6 mo -8.5 -306 -1.3 739 74 +25  - - -  - - - 
Truby baseline 
  
  125 (44)   - 106 (33)   - 136 (60)  
2008 UK 2 mo -5.2 -656 -2.7  92 (38) -26  - 75 (38) -29  - 91 (49) -33 
Gardner baseline 
  
 851 (314) 85   291 (88) 91   14.8 (4.8) 82  
2010 US 2 mo -4.3 -556 -2.3 742 (273) 74 -13  231(86) 72 -21  10.5 (4.1) 58 -29 
Genoni baseline 
  
 771 (204) 77   359 (85) 112   12.7 (2.6) 71  
2016 Aus 4 wk -3.2 -450 -1.9 355 (91) 36 -54  328 (97) 103 -9  11.1 (2.7) 62 -13 
Mardinoglu baseline 
  
 1187 (342) 148   414 (74) 118   15.7 (3.3) 175  
 2018 Sweden 2 wk -1.9 +880 +3.7 1160 (472) 145 -2  338 (49) 97 -18  15.7 (1.6) 171 -2 
Elidottir a,b Men - - - 770 (564) 96 -  245 (148) 70 -  11 (7) 122 - 
2016 Iceland Women - - - 774 (566) 97 -  254 (114) 91 -  9 (6) 60 - 
Values are expressed as mean (SD) unless otherwise indicated. M, men; W, women; wk, week; mo, month; BW, body weight; EI, energy intake; RI, recommended intake. 
a cross-sectional study, b values are median (Interquartile range). 
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Table 4. Mineral intakes, percentage of recommended intakes and changes from baseline (continued). 
    
 Iodine    Zinc    Selenium 
  
 
Time 
points 
BW 
loss 
(kg) 
EI 
change 
(kcal) 
EI change 
(MJ) Intake (µg) %RI 
Baseline 
change 
(%) 
 Intake (µg) %RI 
Baseline 
change 
(%) 
 Intake (µg) %RI Baseline change (%) 
Miller (M) baseline 
  
 - - -  16 (7) 146   167 (68) 304  
2003 US 2 wk -3.8 -1081 -4.5 - - -  14 (5) 127 -13  142 (107) 258 -15 
 
4 wk -5.3 -923 -3.9 - - -  17 (4) 155 +6  146 (54) 266 -13 
Miller (W) baseline 
  
 - - -  10 (2) 125   128 (21) 233  
2003 US 2 wk -3.8 -1081 -4.5 - - -  11 (4) 138 +10  108 (34) 196 -16 
 
4 wk -5.3 -923 -3.9 - - -  12 (6) 150 +20  112 (40) 204 -13 
Brehm baseline 
  
 - - -  - - -  - - - 
2003 US 3 mo -7.6 -452 -1.9 - - -  - - -  - - - 
 
6 mo -8.5 -306 -1.3 - - -  - - -  - - - 
Truby baseline 
  
 - - -  - 119 (33)   - 100 (33)  
2008 UK 2 mo -5.2 -656 -2.7 - - -  - 139 (49) +17  - 149 (225) +49 
Gardner baseline 
  
 - - -  10.7 (3.7) 134   107 (36) 195  
2010 US 2 mo -4.3 -556 -2.3 - - -  11 (3.5) 138 +3  114 (44) 207 +6.5 
Genoni baseline 
  
 120 (39) 80   11.5 (2.4) 144   - - - 
2016 Aus 4 wk -3.2 -450 -1.9 64 (23) 43 -47  11.8 (3.4) 148 +3  - - - 
Mardinoglu baseline 
  
 281 (133) 187   13.8 (2.3) 153   89.7 (34.4) 149  
 2018 Sweden 2 wk -1.9 +880 +3.7 177 (10) 118 -37  15.3 (1) 170 +11  146.5 (8.8) 244 +63 
Elidottir a,b Men - - - - - -  - - -  - - - 
2016 Iceland Women - - - - - -  - - -  - - - 
Values are expressed as mean (SD) unless otherwise indicated. M, men; W, women; wk, week; mo, month; BW, body weight; EI, energy intake; RI, recommended intake. 
a cross-sectional study, b values are median (Interquartile range). 
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Table 5 Micronutrient intakes following carbohydrate-restricted diets compared to control diets. 
 
Brehm (2003)        
 
Truby (2008)   
 
Gardner (2010)   
M
ic
ro
nu
tr
ie
nt
s 3 months 
a    6 months a     2 months b   2 months c  
       %RNI       
Atkins LFD  Atkins LFD  Atkins Control 
 
Atkins LEARN 
(n=22) (n=20)   (n=22) (n=20)   (n=30) (n=26) (n=73) (n=73) 
Thiamine (mg) - -  - -  146 (49) 178 (76)  0.9 (0.4) 1.4 (0.4) * 
Folate (µg) 139.7 221.7  195.9 193.9  93 (44) 114 (36)  329 (141) 470 (190) *** 
Vitamin B12 (µg) - -  - -  - -  6.6 (7.9) 5.7 (10.2) 
Vitamin C (mg) 35.7 94.2 **  58.5 53.1  132 (104) 205 (214)  66 (39) 100 (62) *** 
Vitamin A (µg) - -  - -  175 (257) 118 (66)  743 (323) 689 (327) 
Carotene (µg) - -  - -  - -  - - 
Vitamin E (mg) - -  - -  - -  8.7 (4.8) 7.2 (4.2) 
Magnesium (mg) - -  - -  75 (38) 95 (31)  231 (86) 286 (89) ** 
Calcium (mg) 444.2 567.2  739.0 662.6  92 (38) 111 (41)  742 (273) 801 (339) 
Iron (mg) - -  - -  91 (49) 104 (46)  10.5 (4.1) 13.7 (5.2) *** 
Zinc (µg) - -  - -  139 (49) 103 (31)  11 (3.5) 8.9 (3.1) *** 
Selenium (µg) - -  - -  149 (225) 87 (61)  114 (44) 97 (34) *** 
Iodine (µg) - -   - -   - -   - - 
Values are mean (SD) unless otherwise indicated. CRD, carbohydrate-restricted diet; LFD, low-fat diet; RNI, reference nutrient intake; AGHE, Australian Guideline Healthy Eating. 
* p<0.05, ** p<0.01, *** p<0.001 compared between groups. 
a no SD reported. 
b no statistical comparison between groups 
c P-values obtained from ANOVA, pairwise comparisons were significantly different (Tukey’s Studentised range test) 
d P-values for mean difference of change (end - baseline) between groups   
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Table 5 Micronutrient intakes following carbohydrate-restricted diets compared to control diets (continued). 
 
Bazzano 
(2014)         
 
Genoni (2016) 
 
M
ic
ro
nu
tr
ie
nt
s 3 months 
b    6 months 
b     12 months b    4 weeks d   
            
CRD LFD  CRD LFD  CRD LFD 
 
Paleolithic diet AGHE 
n=62 n=61   n=54 n=50   n=54 n=49  (n=22) (n=17) 
Thiamine (mg) - -  - -  - -  0.96 (0.5) 1.49 (11)* 
Folate (µg) 290 (130) 360 (230)  320 (170) 380 (220)  310 (150) 350 (200)  317(85) 350 (132) 
Vitamin B12 (µg) - -  - -  - -  - - 
Vitamin C (mg) 68 (45) 83 (68)  81 (55) 85 (66)  73 (68) 83 (61)  168 (84) 95.6 (51)* 
Vitamin A (µg) - -  - -  - -  2032 (1359) 984 (679)* 
Carotene (µg) 890 (1990) 990 (2030)  600 (1500) 740 (2440)  420 (1420) 1000 (2350)  11379 (7966) 4386 (3642)** 
Vitamin E (mg) - -  - -  - -  14.3 (7.3) 9 (5)** 
Magnesium (mg) - -  - -  - -  328 (97) 366 (106) 
Calcium (mg) - -  - -  - -  355 (91) 759 (247)** 
Iron (mg) - -  - -  - -  11.1 (2.7) 10.6 (3.2) 
Zinc (µg) - -  - -  - -  11.8 (3.4) 10.3 (3.1) 
Selenium (µg) - -  - -  - -  - - 
Iodine (µg) - -  - -  - -  64 (23) 145 (40)** 
Values are mean (SD) unless otherwise indicated. CRD, carbohydrate-restricted diet; LFD, low-fat diet; RNI, reference nutrient intake; AGHE, Australian Guideline Healthy Eating. 
* p<0.05, ** p<0.01, *** p<0.001 compared between groups. 
a no SD reported. 
b no statistical comparison between groups 
c P-values obtained from ANOVA, pairwise comparisons were significantly different (Tukey’s Studentised range test) 
d P-values for mean difference of change (end - baseline) between groups   
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Table 6. Plasma and urine biomarkers of micronutrients 
Biochemical measures Baseline a End p-value 
Atkins Diet (Johnstone 2011)  4 weeks a  
   Retinol (µg/ml) 0.623 0.456 <0.001 
   α-Tocopherol (µg/ml) 11.46 9.30 <0.001 
   β-Cryptoxanthin (µg/ml) 0.065 0.039 <0.001 
   Lycopene (µg/ml) 0.392 0.244 <0.001 
   α-Carotene (µg/ml) 0.039 0.035 0.002 
   β-Carotene (µg/ml) 0.135 0.132 0.004 
   Xanthophyll (µg/ml) 0.186 0.207 <0.001 
   Vitamin C (µmol/L) 46.5 51.7 <0.001 
    
Paleolithic diet (Genoni 2016)  4 weeks  
   Lycopene (µmol/L) 0.61 ± 0.3 0.52 ± 0.2 ns 
   α-Carotene (µmol/L) 0.39 ± 0.4 0.46 ± 0.2 ns 
   β-Carotene (µmol/L) 1.54 ± 1.3 2.41 ± 1.8 <0.05 
   Red cell folate (nmol/L) 894 ± 214 981 ± 300 <0.01 
    
‘Isocaloric’ CRD (Mardinoglu 
2018)  2 weeks  
   Serum folate (nmol/L) 25.6±4.1 34.5±5.5 <0.001 
    
Paleolithic diet (Manousou 
2018)  6 months 
b End (2 years) b 
   24-h UIC (µg/L) 68 (IQR 37) 36 (IQR 36), p=0.001 57 (IQR 32), p=0.033 
   24-h UIE (µg/L) 124.5 (IQR 88) 77 (IQR 65), p=0.001 113.5 (IQR 79), ns 
    
   Proportion of subjects 
according    
   to 24-h UIC, n (%) 
Baseline  
(n=34) 
6 months 
(n=30) p-value 
c 
      <50 µg/L 5 (15) 22 (73) 0.001 
      51-100 µg/L 23 (68) 5 (17) 0.001 
      101-200 µg/L 6 (18) 3 (10) ns 
      >200 µg/L 0 0  
Values are mean ± SD unless otherwise indicated.  
CRD, carbohydrate-restricted diet; UIC, urine iodine concentration; UIE, urine iodine excretion; IQR, 
interquartile range; ns, not significant 
a no SD reported 
b p-value compared to baseline 
c p-value from the longitudinal analysis compared to baseline 
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